Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis

被引：122

作者：

Lazennec, G ^{[1
]}

机构：

[1] INSERM, U540, F-34090 Montpellier, France

来源：

CANCER LETTERS | 2006年 / 231卷 / 02期

关键词：

ovarian cancer; estrogen receptor; tumor-suppressor;

D O I：

10.1016/j.canlet.2005.01.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Ovarian cancer is one of the leading causes of death from gynecological tumors in women. Several lines of evidence Suggest that estrogens may play an important role in ovarian carcinogenesis, through their receptor, ER alpha and ER beta. Interestingly, malignant ovarian tumours Originating from epithelial Surface constitute about 90% of ovarian cancers and expressed low levels of ER beta, compared to normal tissues. In addition, restoration of ER beta in ovarian cancer cells, leads to strong inhibition of their proliferation and invasion, while apoptosis is enhanced. In this manuscript, recent data suggesting a possible tumour-suppressor role for ER beta in ovarian carcinogenesis are discussed. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

引用

收藏

页码：151 / 157

页数：7

相关论文

共 78 条

[31] Estrogen receptor β is coexpressed with ERα and PR and associated with nodal status, grade, and proliferation rate in breast cancer [J].

Järvinen, TAH ;

Pelto-Huikko, M ;

Holli, K ;

Isola, J .

AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (01) :29-35

[32] Phylogenetic analyses reveal ancient duplication of estrogen receptor isoforms [J].

Kelley, ST ;

Thackray, VG .

JOURNAL OF MOLECULAR EVOLUTION, 1999, 49 (05) :609-614

[33] STEROID-RECEPTORS IN OVARIAN-CARCINOMA - IMMUNOHISTOCHEMICAL DETERMINATION MAY LEAD TO NEW ASPECTS [J].

KOMMOSS, F ;

PFISTERER, J ;

THOME, M ;

SCHAFER, W ;

SAUERBREI, W ;

PFLEIDERER, A .

GYNECOLOGIC ONCOLOGY, 1992, 47 (03) :317-322

[34] Endocrine-resistant breast cancer: Underlying mechanisms and strategies for overcoming resistance [J].

Junichi Kurebayashi .

Breast Cancer, 2003, 10 (2) :112-119

[35] Menopausal hormone replacement therapy and risk of ovarian cancer [J].

Lacey, JV ;

Mink, PJ ;

Lubin, JH ;

Sherman, ME ;

Troisi, R ;

Hartge, P ;

Schatzkin, A ;

Schairer, C .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :334-341

[36] Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells [J].

Lau, KM ;

Mok, SC ;

Ho, SM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5722-5727

[37] ERβ inhibits proliferation and invasion of breast cancer cells [J].

Lazennec, G ;

Bresson, D ;

Lucas, A ;

Chauveau, C ;

Vignon, F .

ENDOCRINOLOGY, 2001, 142 (09) :4120-4130

[38] Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells [J].

Lazennec, G ;

Katzenellenbogen, BS .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 149 (1-2) :93-105

[39] Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures [J].

Li, AJ ;

Baldwin, RL ;

Karlan, BY .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (01) :22-27

[40] Cloning and characterization of human estrogen receptor β promoter [J].

Li, LC ;

Yeh, CC ;

Nojima, D ;

Dahiya, R .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (02) :682-689

← 1 2 3 4 5 6 7 8 →